OSI Pharmaceuticals

pharmaceutical development for cancer and diabetes treatments

History:

OSI Pharmaceuticals was acquired by Astellas in 2010.

Acquisitions:
Eyetech Pharmaceuticals (2005)
Prosidion

Employment

Email:

Fax:

Mail:

General Info:

Ticker: OSIP

Employees:

Regions:
Northeast Other US Europe

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: